4//SEC Filing
REXAHN PHARMACEUTICALS, INC. 4
Accession 0000893838-07-000190
$IRDCIK 0001228627operating
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:15 PM ET
Size
9.5 KB
Accession
0000893838-07-000190
Insider Transaction Report
Form 4
McIntosh David M
Director
Transactions
- Award
Stock Option (Right to Buy)
2007-06-11+20,000→ 20,000 totalExercise: $1.40From: 2008-06-11Exp: 2017-06-11→ Common Stock (20,000 underlying)
Holdings
- 125,000
Stock Option (Right to Buy)
Exercise: $0.80Exp: 2014-04-20→ Common Stock (125,000 underlying) - 20,000
Stock Option (Right to Buy)
Exercise: $3.00From: 2006-09-12Exp: 2015-09-12→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Options fully vest on the first anniversay of the date of grant.
- [F2]30% of the options vested and became exercisable on April 20, 2005; another 30% of the options vested and became exercisable on April 20, 2006; and the remaining 40% of the options vested and became exercisable on April 20, 2007.
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001228627
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:15 PM ET
- Size
- 9.5 KB